NKGen Biotech, Inc. Common Stock (NKGN )

Currency in USD Disclaimer
$0.23 -$0.02 (-6.54%)
Closed 10/15/2024
$0.2
$0.26
$0.2
$5.1

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol NKGN
  • Company NKGen Biotech, Inc. Common Stock
  • Price $0.23
  • Changes Percentage -6.54
  • Change -0.0161
  • Day Low $0.2
  • Day High $0.26
  • Year High $5.1
  • Year Low $0.2
  • Market Cap $8,170,612
  • Price Avg 50 EMA (D) $0.65
  • Price Avg 200 EMA (D) $1.36
  • Exchange NASDAQ
  • Volume 731,861
  • Average Volume 938,935
  • Open $0.26
  • Previous Close $0.25
  • EPS -3.42
  • PE -0.07
  • Earnings Announcement 2024-11-12 00:00:00
  • Shares Outstanding $35,524,400

Company brief: NKGEN BIOTECH, INC. COMMON STOCK (NKGN )

Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.

NKGN Corporation News

NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)

NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)

October 15, 2024 at 8:05 am ET

globenewswire.com -- SANTA ANA, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commerc...

Income Statement